Finally, immunofluorescence indicated that SB225002 or U0126 treatment significantly decreased the percentage of CD16/32 and CD11b double-positive microglia after meningitic E. coli infection compared to those without SB225002 or U0126 treatment (Figure 6). The gene discussed is ITGAM; the disease is escherichia coli infection.